1. Kubota K, Ishiwata K, Kubota R, et al. Tracer feasibility for monitoring tumor radiotherapy: A quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine- 18-fluorodeoxyuridine, l-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.J Nucl Med 1991; 32:2118–2123.
2. Tjuvajev J, Muraki A, Ginos J, et al. Iododeoxyuridine uptake and retention as a measure of tumor growth.J Nucl Med 1993; 34: 1152–1162.
3. Strauss LG, Conti PS. The application of PET in clinical oncology.J Nucl Med 1991; 32: 623–648.
4. Ohtsuki K, Akashi K, Aoka Y, et al. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for thein-vivo detection of apoptosis.Eur J Nucl Med 1999; 26 (10): 1251–1258.
5. Vriens PW, Blankenberg FG, Stoot JH, et al. The use of technetium99mTc annexin V forin vivo imaging of apoptosis during cardiac allograft rejection.J Thorac Cardiovasc Surg 1998; 116:844–853.